Records containing: Melanoma (Skin)
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2014-01-06PHASE III TRIAL OF MELACINE PLUS INTERFERON ALFA-2B VERSUS INTERFERON ALFA-2B IN PATIENTS WITH DISSEMINATED MALIGNANT MELANOMA
-
CLINICAL_TRIALS study record update · 2014-01-06Continuation Protocol For G3139 (Bcl-2 Antisense Oligonucleotide) And Dacarbazine In Patients With Malignant Melanoma Who Responded To This Combination In Protocol GM301
-
CLINICAL_TRIALS study record update · 2014-01-06Randomized Study Of Dacarbazine Versus Dacarbazine Plus G3139 (Bcl-2 Antisense Oligonucleotide) In Patients With Advanced Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2014-01-06Phase I/II Trial Investigating The Safety And Immunogenicity Of Adenoviruses Encoding The Melan-A/MART-1 And gp 100 Melanoma Antigens Administered Intradermally To Patients With Stage II-IV Melanoma
-
CLINICAL_TRIALS study record update · 2013-12-19Response of In-Transit Melanoma to Systemic Treatment With the Specific Active Immunotherapeutic Agent, Canvaxin™
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-12-19An Open-Label, Multicenter, Phase II Trial of ABI-007 (A Cremophor® -Free, Protein Stabilized, Nanoparticle Paclitaxel) in Previously Treated Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2013-12-19TREATMENT OF METASTATIC MELANOMA WITH RECOMBINANT INTERLEUKIN-2
-
CLINICAL_TRIALS study record update · 2013-12-19A RANDOMISED STUDY OF OBSERVATION VERSUS ADJUVANT LOW DOSE EXTENDED DURATION INTERFERON ALPHA-2A IN COMPLETELY RESECTED HIGH RISK MALIGNANT MELANOMA
-
CLINICAL_TRIALS study record update · 2013-12-18Development of an Electrical Diagnostic for Melanoma and Other Cutaneous Malignancies
-
CLINICAL_TRIALS study record update · 2013-12-18A Phase I Study of Peptide Based Vaccine Therapy in Patients With High-Risk or Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2013-12-18Efficacy of Web-Based Instruction on Skin Cancer Triage
-
CLINICAL_TRIALS study record update · 2013-12-18A Phase III, Multi-Center Controlled Trial With Stratified Randomization Comparing The Efficacy Of Interleukin-2 (IL-2) Plus Histamine Dihydrochloride (HDC) Versus IL-2 Alone To Increase The Duration Of Survival In Patients With AJCC Stage IV Malignant Melanoma With Hepatic Metastasis
-
CLINICAL_TRIALS study record update · 2013-12-18A Phase I Trial of Intra Lesional rV-Tricom Vaccine in the Treatment of Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2013-12-10Evaluation of the Clinical Efficacy of Leukine® Administered in Conjunction With Paclitaxel in Patients With Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2013-12-04Phase II Evaluation of RFS 2000 (9-Nitro-Camptothecin, 9NC) in Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2013-11-06A Phase 1/2 Uncontrolled, Open Label Study Of Photodynamic Vaccination In Patients With Stage III/IV Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2013-11-06A Phase II Study Of Matured Dendritic Cells Pulsed Ex Vivo With 3 Melanoma Cell Line Lysates (IDD-3) in Patients With In-Transit or Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2013-10-07Multicenter Parallel Phase II Trial of BI 2536 Administered as One Hour IV Infusion Every 3 Weeks in Defined Cohorts of Patients With Various Solid Tumors. A New Drug Screening Program of the EORTC Network of Core Institutions (NOCI)
-
CLINICAL_TRIALS study record update · 2013-09-20Interleukin 12-Primed Activated T Cells As Therapy For Patients With Metastatic Melanoma (Phase I)
-
CLINICAL_TRIALS study record update · 2013-09-20Phase I (Tumour Site Specific) Study of Carboplatin and Temozolomide in Patients With Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2013-09-17Vaccination of Stage IV Cutaneous Melanoma Patients With Mature, Autologous Monocyte-Derived Dendritic Cells Transfected With Unselected Autologous Amplified Tumor-RNA
-
CLINICAL_TRIALS study record update · 2013-09-17An Open Label Lesion Controlled Study of Electroporation Therapy (EPT) for the Treatment of Cutaneous Metastatic Melanoma Using the Genetronics, Inc. Medpulser System and Bleomycin
-
CLINICAL_TRIALS study record update · 2013-09-17PROCEDURES FOR BNCT PHASE-I STUDY OF MELANOMA IN THE EXTREMITIES
-
CLINICAL_TRIALS study record update · 2013-09-17Mature Dendritic Cell Immunotherapy Of Metastatic Melanoma- A Phase I Trial
-
CLINICAL_TRIALS study record update · 2013-09-05Phase II Study of Outpatient CDDP and DTIC Followed by GM-CSF, IFN-a2b, and IL-2 in Patients With Advanced Melanoma